{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:27:52Z","timestamp":1793672872760,"version":"4.5.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","award":["Alexion Pharmaceuticals"],"award-info":[{"award-number":["Alexion Pharmaceuticals"]}],"id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Plexiform neurofibromas (PNs) are among the most complex and challenging manifestations of neurofibromatosis type 1 (NF1). Recent advances in understanding their epidemiology, natural history, biology, and imaging features, together with the introduction of MEK inhibitors, have significantly reshaped clinical management. Despite availability of international recommendations for tumor surveillance in NF1, several aspects of PN management remain incompletely defined in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multidisciplinary panel of 17 Italian NF1 experts conducted a Real-Time Delphi consensus process including a literature review, thematic analysis, and development of consensus statements. Key domains encompassed diagnosis, imaging assessment, surveillance, surgical evaluation, multidisciplinary management, and treatment of PNs. Two rounds of voting were conducted through a dedicated online platform, ensuring anonymity, real-time feedback, and iterative refinement of the statements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Consensus was achieved on 49 final statements. Key recommendations emphasized the importance of early identification of PNs, assessment of internal tumor burden through whole-body MRI, standardized imaging acquisition and reporting, timely recognition and characterization of distinct nodular lesions, and implementation of risk-adapted surveillance strategies. The panel also underscored the importance of patient education regarding signs suggestive of malignant transformation, and recommended a structured multidisciplinary approach to clinical decision-making. Agreement was additionally reached on practical aspects including radiological follow-up, criteria for surgical referral, definitions of PN-related symptoms, inoperability, and integration of surgical and targeted treatment strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This national consensus provides an evidence-informed and clinically oriented framework for management of NF1-associated PNs. Complementing existing international recommendations, it offers practical guidance in areas where evidence remains limited.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10072-026-09290-z","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:31:55Z","timestamp":1790141515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of plexiform neurofibromas in neurofibromatosis type 1: An Italian Delphi consensus"],"prefix":"10.1007","volume":"47","author":[{"given":"Claudia","family":"Santoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Arkhangelskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambra","family":"Bonvicino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Diana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Eoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Ionna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Macchiaiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Marulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Nazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Trevisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martino","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4830-6204","authenticated-orcid":false,"given":"Veronica","family":"Saletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"9290_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/B978-0-444-52902-2.00053-9","volume":"115","author":"RE Ferner","year":"2013","unstructured":"Ferner RE, Gutmann DH (2013) Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol 115:939\u2013955. https:\/\/doi.org\/10.1016\/B978-0-444-52902-2.00053-9","journal-title":"Handb Clin Neurol"},{"key":"9290_CR2","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P et al (2021) Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med 23:1506\u20131513. https:\/\/doi.org\/10.1038\/s41436-021-01170-5","journal-title":"Genet Med"},{"key":"9290_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-pathol-011811-132441","volume":"7","author":"K Staser","year":"2012","unstructured":"Staser K, Yang F-C, Clapp DW (2012) Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal\/Hematopoietic Interactions in Tumor Progression. Annu Rev Pathol Mech Dis 7:469\u2013495. https:\/\/doi.org\/10.1146\/annurev-pathol-011811-132441","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"9290_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro-Oncol"},{"key":"9290_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/his.14265","volume":"78","author":"WJ Anderson","year":"2021","unstructured":"Anderson WJ, Doyle LA (2021) Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours. Histopathology 78:644\u2013657. https:\/\/doi.org\/10.1111\/his.14265","journal-title":"Histopathology"},{"key":"9290_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071930","volume":"15","author":"A Pellerino","year":"2023","unstructured":"Pellerino A, Verdijk RM, Nichelli L et al (2023) Diagnosis and treatment of peripheral and cranial nerve tumors with expert recommendations: an EUropean network for RAre CANcers (EURACAN) initiative. Cancers 15:1930. https:\/\/doi.org\/10.3390\/cancers15071930","journal-title":"Cancers"},{"key":"9290_CR7","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1093\/neuonc\/noac146","volume":"24","author":"MJ Fisher","year":"2022","unstructured":"Fisher MJ, Blakeley JO, Weiss BD et al (2022) Management of neurofibromatosis type 1-associated plexiform neurofibromas. Neuro-Oncol 24:1827\u20131844. https:\/\/doi.org\/10.1093\/neuonc\/noac146","journal-title":"Neuro-Oncol"},{"key":"9290_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","volume":"67","author":"MM Miettinen","year":"2017","unstructured":"Miettinen MM, Antonescu CR, Fletcher CDM et al (2017) Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1\u2014a consensus overview. Hum Pathol 67:1\u201310. https:\/\/doi.org\/10.1016\/j.humpath.2017.05.010","journal-title":"Hum Pathol"},{"key":"9290_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/neuonc\/noy013","volume":"20","author":"CS Higham","year":"2018","unstructured":"Higham CS, Dombi E, Rogiers A et al (2018) The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors. Neuro-Oncol 20:818\u2013825. https:\/\/doi.org\/10.1093\/neuonc\/noy013","journal-title":"Neuro-Oncol"},{"key":"9290_CR10","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","volume":"382","author":"AM Gross","year":"2020","unstructured":"Gross AM, Wolters PL, Dombi E et al (2020) Selumetinib in Children with Inoperable Plexiform Neurofibromas. N Engl J Med 382:1430\u20131442. https:\/\/doi.org\/10.1056\/NEJMoa1912735","journal-title":"N Engl J Med"},{"key":"9290_CR11","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/S0140-6736(25)00986-9","volume":"405","author":"AP Chen","year":"2025","unstructured":"Chen AP, Coyne GO, Wolters PL et al (2025) Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study. Lancet 405:2217\u20132230. https:\/\/doi.org\/10.1016\/S0140-6736(25)00986-9","journal-title":"Lancet"},{"key":"9290_CR12","doi-asserted-by":"publisher","unstructured":"Moertel CL, Hirbe AC, Shuhaiber HH et al (2025) ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma. J Clin Oncol 43:716\u2013729. https:\/\/doi.org\/10.1200\/JCO.24.0103413","DOI":"10.1200\/JCO.24.0103413"},{"key":"9290_CR13","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/neuonc\/noaa053","volume":"22","author":"S Akshintala","year":"2020","unstructured":"Akshintala S, Baldwin A, Liewehr DJ et al (2020) Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions. Neuro-oncol 22:1368\u20131378. https:\/\/doi.org\/10.1093\/neuonc\/noaa053","journal-title":"Neuro-oncol"},{"key":"9290_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/neuonc\/noae235","volume":"27","author":"C-HG Lucas","year":"2025","unstructured":"Lucas C-HG, Gross AM, Romo CG et al (2025) Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1. Neuro-Oncol 27:616\u2013624. https:\/\/doi.org\/10.1093\/neuonc\/noae235","journal-title":"Neuro-Oncol"},{"key":"9290_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40487-022-00213-4","volume":"11","author":"C Ejerskov","year":"2023","unstructured":"Ejerskov C, Farholt S, Nielsen FSK et al (2023) Clinical Characteristics and Management of Children and Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas in Denmark: A Nationwide Study. Oncol Ther 11:97\u2013110. https:\/\/doi.org\/10.1007\/s40487-022-00213-4","journal-title":"Oncol Ther"},{"key":"9290_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101818","volume":"56","author":"C Carton","year":"2023","unstructured":"Carton C, Evans DG, Blanco I et al (2023) ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. eClinicalMedicine 56:101818. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101818","journal-title":"eClinicalMedicine"},{"key":"9290_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","volume":"311","author":"J Jones","year":"1995","unstructured":"Jones J, Hunter D (1995) Qualitative Research: Consensus methods for medical and health services research. BMJ 311:376\u2013380. https:\/\/doi.org\/10.1136\/bmj.311.7001.376","journal-title":"BMJ"},{"key":"9290_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12912-021-00661-9","volume":"20","author":"W Varndell","year":"2021","unstructured":"Varndell W, Fry M, Elliott D (2021) Applying real-time Delphi methods: development of a pain management survey in emergency nursing. BMC Nurs 20:149. https:\/\/doi.org\/10.1186\/s12912-021-00661-9","journal-title":"BMC Nurs"},{"key":"9290_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63962-4","volume":"14","author":"J Domaradzki","year":"2024","unstructured":"Domaradzki J, Walkowiak D (2024) Invisible patients in rare diseases: parental experiences with the healthcare and social services for children with rare diseases. A mixed method study. Sci Rep 14:14016. https:\/\/doi.org\/10.1038\/s41598-024-63962-4","journal-title":"Sci Rep"},{"key":"9290_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","volume":"67","author":"IR Diamond","year":"2014","unstructured":"Diamond IR, Grant RC, Feldman BM et al (2014) Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol 67:401\u2013409. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.12.002","journal-title":"J Clin Epidemiol"},{"key":"9290_CR21","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","volume":"111","author":"SM Huson","year":"1988","unstructured":"Huson SM, Harper PS, Compston DAS (1988) VON RECKLINGHAUSEN NEUROFIBROMATOSIS: A CLINICAL AND POPULATION STUDY IN SOUTH-EAST WALES. Brain 111:1355\u20131381. https:\/\/doi.org\/10.1093\/brain\/111.6.1355","journal-title":"Brain"},{"key":"9290_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/(SICI)1096-8628(20000515)92:2<132::AID-AJMG10>3.0.CO;2-6","volume":"92","author":"DJ Waggoner","year":"2000","unstructured":"Waggoner DJ, Towbin J, Gottesman G, Gutmann DH (2000) Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Am J Med Genet 92:132\u2013135","journal-title":"Am J Med Genet"},{"key":"9290_CR23","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ajmg.a.62691","volume":"188","author":"YC Collins-Sawaragi","year":"2022","unstructured":"Collins-Sawaragi YC, Ferner R, Vassallo G et al (2022) Location, symptoms, and management of plexiform neurofibromas in 127 children with neurofibromatosis 1, attending the National Complex Neurofibromatosis 1 service, 2018\u20132019. Am J Med Genet A 188:1723\u20131727. https:\/\/doi.org\/10.1002\/ajmg.a.62691","journal-title":"Am J Med Genet A"},{"key":"9290_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035711","volume":"7","author":"SR Plotkin","year":"2012","unstructured":"Plotkin SR, Bredella MA, Cai W et al (2012) Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One 7:e35711. https:\/\/doi.org\/10.1371\/journal.pone.0035711","journal-title":"PLoS One"},{"key":"9290_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1215\/15228517-2008-011","volume":"10","author":"V-F Mautner","year":"2008","unstructured":"Mautner V-F, Asuagbor FA, Dombi E et al (2008) Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro-Oncol 10:593\u2013598. https:\/\/doi.org\/10.1215\/15228517-2008-011","journal-title":"Neuro-Oncol"},{"key":"9290_CR26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jpeds.2011.04.008","volume":"159","author":"R Nguyen","year":"2011","unstructured":"Nguyen R, Kluwe L, Fuensterer C et al (2011) Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits. J Pediatr 159:652-655.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2011.04.008","journal-title":"J Pediatr"},{"key":"9290_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1148\/rg.2018170165","volume":"38","author":"AG Bansal","year":"2018","unstructured":"Bansal AG, Oudsema R, Masseaux JA, Rosenberg HK (2018) US of Pediatric Superficial Masses of the Head and Neck. Radiographics 38:1239\u20131263. https:\/\/doi.org\/10.1148\/rg.2018170165","journal-title":"Radiographics"},{"key":"9290_CR28","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00701-020-04257-1","volume":"162","author":"C Pendleton","year":"2020","unstructured":"Pendleton C, Spinner RJ (2020) Image-guided percutaneous biopsy of peripheral nerve tumors of indeterminate nature: risks and benefits. Acta Neurochir (Wien) 162:1425\u20131429. https:\/\/doi.org\/10.1007\/s00701-020-04257-1","journal-title":"Acta Neurochir (Wien)"},{"key":"9290_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jcu.22769","volume":"48","author":"M T\u00f8ttrup","year":"2020","unstructured":"T\u00f8ttrup M, Eriksen JD, Hellfritzsch MB et al (2020) Diagnostic accuracy of ultrasound-guided core biopsy of peripheral nerve sheath tumors. J Clin Ultrasound 48:134\u2013138. https:\/\/doi.org\/10.1002\/jcu.22769","journal-title":"J Clin Ultrasound"},{"key":"9290_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.nic.2013.03.035","volume":"24","author":"S Ahlawat","year":"2014","unstructured":"Ahlawat S, Chhabra A, Blakely J (2014) Magnetic Resonance Neurography of Peripheral Nerve Tumors and Tumorlike Conditions. Neuroimaging Clin N Am 24:171\u2013192. https:\/\/doi.org\/10.1016\/j.nic.2013.03.035","journal-title":"Neuroimaging Clin N Am"},{"key":"9290_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.hansur.2016.08.001","volume":"35","author":"G Chick","year":"2016","unstructured":"Chick G, Hollevoet N, Victor J, Bianchi S (2016) The role of imaging in isolated benign peripheral nerve tumors: a practical review for surgeons. Hand Surg Rehabil 35:320\u2013329. https:\/\/doi.org\/10.1016\/j.hansur.2016.08.001","journal-title":"Hand Surg Rehabil"},{"key":"9290_CR32","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000435744.57038.af","author":"E Dombi","year":"2013","unstructured":"Dombi E, Ardern-Holmes SL, Babovic-Vuksanovic D et al (2013) Recommendations for imaging tumor response in neurofibromatosis clinical trials. Neurology 81(21 Suppl 1):S33\u2013S40. https:\/\/doi.org\/10.1212\/01.wnl.0000435744.57038.af","journal-title":"Neurology"},{"key":"9290_CR33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201535","author":"KI Ly","year":"2023","unstructured":"Ly KI, Merker VL, Cai W et al (2023) Ten-year follow-up of internal neurofibroma growth behavior in adult patients with neurofibromatosis type 1 using whole-body MRI. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000201535","journal-title":"Neurology"},{"key":"9290_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1212\/01.wnl.0000250332.89420.e6","volume":"68","author":"E Dombi","year":"2007","unstructured":"Dombi E, Solomon J, Gillespie AJ et al (2007) NF1 plexiform neurofibroma growth rate by volumetric MRI: Relationship to age and body weight. Neurology 68:643\u2013647. https:\/\/doi.org\/10.1212\/01.wnl.0000250332.89420.e6","journal-title":"Neurology"},{"key":"9290_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1750-1172-7-75","volume":"7","author":"R Nguyen","year":"2012","unstructured":"Nguyen R, Dombi E, Widemann BC et al (2012) Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1. Orphanet J Rare Dis 7:75. https:\/\/doi.org\/10.1186\/1750-1172-7-75","journal-title":"Orphanet J Rare Dis"},{"key":"9290_CR36","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jpeds.2013.10.081","volume":"164","author":"U Dagalakis","year":"2014","unstructured":"Dagalakis U, Lodish M, Dombi E et al (2014) Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type I. J Pediatr 164:620\u2013624. https:\/\/doi.org\/10.1016\/j.jpeds.2013.10.081","journal-title":"J Pediatr"},{"key":"9290_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232031","volume":"15","author":"L Well","year":"2020","unstructured":"Well L, Jaeger A, Kehrer-Sawatzki H et al (2020) The effect of pregnancy on growth-dynamics of neurofibromas in neurofibromatosis type 1. PLoS One 15:e0232031. https:\/\/doi.org\/10.1371\/journal.pone.0232031","journal-title":"PLoS One"},{"key":"9290_CR38","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jpeds.2011.08.051","volume":"160","author":"CE Prada","year":"2012","unstructured":"Prada CE, Rangwala FA, Martin LJ et al (2012) Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1. J Pediatr 160:461\u2013467. https:\/\/doi.org\/10.1016\/j.jpeds.2011.08.051","journal-title":"J Pediatr"},{"key":"9290_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010123","volume":"17","author":"B De Brons","year":"2025","unstructured":"De Brons B, Dhaenens B, Van Minkelen R, Oostenbrink R (2025) Identification of the determinants of plexiform neurofibroma morbidity in pediatric and young adult neurofibromatosis type 1 patients: a pilot multivariate approach. Cancers 17:123. https:\/\/doi.org\/10.3390\/cancers17010123","journal-title":"Cancers"},{"key":"9290_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/genes16060645","volume":"16","author":"G Miele","year":"2025","unstructured":"Miele G, Russo I, Filipponi L et al (2025) Clinical efficacy of selumetinib in alleviating neuropathic pain associated with plexiform neurofibroma: a case series. Genes 16:645. https:\/\/doi.org\/10.3390\/genes16060645","journal-title":"Genes"},{"key":"9290_CR41","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s11060-025-05197-5","volume":"175","author":"C Santoro","year":"2025","unstructured":"Santoro C, Servedio M, Diana MC et al (2025) Real-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective study. J Neurooncol 175:1027\u20131037. https:\/\/doi.org\/10.1007\/s11060-025-05197-5","journal-title":"J Neurooncol"},{"key":"9290_CR42","doi-asserted-by":"crossref","unstructured":"Adeyemi A et al MSR8 Psychometric Validation of the PAINS-pNF Target Plexiform Neurofibroma (PN) Pain Severity Score Using Data From KOMET (NCT04924608). Value in Health, Volume 27, Issue 12, S439","DOI":"10.1016\/j.jval.2024.10.2242"},{"key":"9290_CR43","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10897-015-9829-5","volume":"24","author":"HA Crawford","year":"2015","unstructured":"Crawford HA, Barton B, Wilson MJ et al (2015) The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults. J Genet Couns 24:931\u2013944. https:\/\/doi.org\/10.1007\/s10897-015-9829-5","journal-title":"J Genet Couns"},{"key":"9290_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/children11081033","volume":"11","author":"ND Cavallo","year":"2024","unstructured":"Cavallo ND, Maietta P, Perrotta S et al (2024) Quality of life in children with neurofibromatosis type 1: agreement between parents and patients, and the role of disease severity and visibility. Children (Basel) 11:1033. https:\/\/doi.org\/10.3390\/children11081033","journal-title":"Children (Basel)"},{"key":"9290_CR45","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1086\/374821","volume":"72","author":"T De Raedt","year":"2003","unstructured":"De Raedt T, Brems H, Wolkenstein P et al (2003) Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72:1288\u20131292. https:\/\/doi.org\/10.1086\/374821","journal-title":"Am J Hum Genet"},{"key":"9290_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","volume":"102","author":"M Koczkowska","year":"2018","unstructured":"Koczkowska M, Chen Y, Callens T et al (2018) Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844\u2013848. Am J Hum Genet 102:69\u201387. https:\/\/doi.org\/10.1016\/j.ajhg.2017.12.001","journal-title":"Am J Hum Genet"},{"key":"9290_CR47","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s00415-023-12127-w","volume":"271","author":"B Zhu","year":"2024","unstructured":"Zhu B, Zheng T, Wang W et al (2024) Genotype\u2013phenotype correlations of neurofibromatosis type 1: a cross-sectional study from a large Chinese cohort. J Neurol 271:1893\u20131900. https:\/\/doi.org\/10.1007\/s00415-023-12127-w","journal-title":"J Neurol"},{"key":"9290_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17081306","volume":"17","author":"MP Iasella","year":"2025","unstructured":"Iasella MP, Ruttens D, Hompes D et al (2025) Close follow-up of patients with neurofibromatosis type 1 reduces the incidence of malignant peripheral nerve sheath tumour. Cancers (Basel) 17:1306. https:\/\/doi.org\/10.3390\/cancers17081306","journal-title":"Cancers (Basel)"},{"key":"9290_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10996-y","volume":"23","author":"AE Armstrong","year":"2023","unstructured":"Armstrong AE, Belzberg AJ, Crawford JR et al (2023) Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas. BMC Cancer 23:553. https:\/\/doi.org\/10.1186\/s12885-023-10996-y","journal-title":"BMC Cancer"},{"key":"9290_CR50","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1001\/archotol.131.8.712","volume":"131","author":"JB Wise","year":"2005","unstructured":"Wise JB, Cryer JE, Belasco JB et al (2005) Management of Head and Neck Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis Type 1. Arch Otolaryngol Neck Surg 131:712. https:\/\/doi.org\/10.1001\/archotol.131.8.712","journal-title":"Arch Otolaryngol Neck Surg"},{"key":"9290_CR51","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/BPO.0b013e31820cad77","volume":"31","author":"F Canavese","year":"2011","unstructured":"Canavese F, Krajbich JI (2011) Resection of plexiform neurofibromas in children with neurofibromatosis type 1. J Pediatr Orthop 31:303\u2013311. https:\/\/doi.org\/10.1097\/BPO.0b013e31820cad77","journal-title":"J Pediatr Orthop"},{"key":"9290_CR52","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0022-3476(97)70092-1","volume":"131","author":"MN Needle","year":"1997","unstructured":"Needle MN, Cnaan A, Dattilo J et al (1997) Prognostic signs in the surgical management of plexiform neurofibroma: The Children\u2019s Hospital of Philadelphia experience, 1974\u20131994. J Pediatr 131:678\u2013682. https:\/\/doi.org\/10.1016\/S0022-3476(97)70092-1","journal-title":"J Pediatr"},{"key":"9290_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-7819-3-6","volume":"3","author":"RE Friedrich","year":"2005","unstructured":"Friedrich RE, Schmelzle R, Hartmann M et al (2005) Resection of small plexiform neurofibromas in neurofibromatosis type 1 children. World J Surg Oncol 3:6. https:\/\/doi.org\/10.1186\/1477-7819-3-6","journal-title":"World J Surg Oncol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09290-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09290-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09290-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:02:57Z","timestamp":1793671377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09290-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["9290"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09290-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"801"}}